Answers are grounded in this paper and cite their sources.
Characterizes pediatric hospitalizations involving COVID-19 and multisystem inflammatory syndrome, indicating the importance of vaccination and coinfection surveillance.
70/wr/mm7045e1.htm?s_cid=mm7045e1_w † † COVID-19 was confirmed with laboratory detection of SARS-CoV-2 by reverse transcription-polymerase chain reaction or antigen test.§ § Patients with MIS-C as the reason for hospitalization included patients who met the clinical case definition for MIS-C (clinically severe illness requiring hospitalization in a person aged <21 years with fever, laboratory evidence of inflammation, multisystem [≥2] organ involvement and no alternative plausible diagnosis, and evidence of current or recent SARS-CoV-2 infection by reverse transcription polymerase chain reaction, serology or antigen test, or COVID-19 exposure within the 4 weeks preceding symptom onset [https:// emergency.cdc.gov/han/2020/han00432.asp]) and were hospitalized for diagnosis and management of MIS-C, based on chart review.¶ ¶ Patients were considered to have a viral coinfection if they had ≥1 of the following infections: type A influenza, type B influenza, unspecified influenza, coronavirus 229e, coronavirus hku1, coronavirus nl63, coronavirus 0c43, respiratory syncytial virus, adenovirus, parainfluenza type 1, parainfluenza type 2, parainfluenza type 3, parainfluenza type 4, human metapneumovirus, rhinovirus, enterovirus, or other viral coinfection.*** Fully vaccinated was defined as having received 2 doses of an mRNA-based COVID-19 vaccine ≥14 days before hospital admission date.Partially vaccinated was defined as having received only 1 dose of an mRNA-based COVID-19 vaccine ≥14 days before hospitalization.All vaccinated patients in this study received the Pfizer-BioNTech (BNT162b2) vaccine.
No takes yet. Share an insight, caveat, or question.
Wanga et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: